James River Group Holdings, Inc. - Q1 2026 10-Q Summary
Business Context and Reporting Period
This Form 10-Q covers the quarterly period ended March 31, 2026. James River Group Holdings, Inc. (formerly James River Group Holdings, Ltd.) completed a domestication from Bermuda to Delaware on November 7, 2025. The Company operates three reportable segments: Excess & Surplus Lines, Specialty Admitted Insurance, and Corporate & Other. The Company's former Casualty Reinsurance segment (JRG Re) was sold in April 2024 and is reported as discontinued operations.
Key Financial Metrics
| Metric | Q1 2026 | Q1 2025 |
|---|---|---|
| Net Written Premiums | $120.1 million | $128.0 million |
| Net Earned Premiums | $135.7 million | $151.9 million |
| Net Investment Income | $21.3 million | $20.0 million |
| Net Realized/Unrealized Investment Losses | ($6.6 million) | ($1.4 million) |
| Net Loss from Continuing Operations | ($8.8 million) | $11.0 million |
| Net Loss Available to Common Shareholders | ($10.9 million) | $7.6 million |
| Combined Ratio (Excl. Retroactive Reinsurance) | 104.6% | 99.5% |
| Total Assets | $4.76 billion | $4.86 billion |
| Shareholders' Equity | $518.4 million | $538.2 million |
| Senior Debt Outstanding | $225.8 million | $225.8 million |
Material Changes vs. Prior Period
- Underwriting Performance: The Company reported an underwriting loss of $6.2 million (Combined Ratio 104.6%) compared to a profit of $0.7 million (Combined Ratio 99.5%) in Q1 2025. The deterioration was driven by a higher loss ratio (69.2% vs. 66.8%) and expense ratio (35.4% vs. 32.7%).
- Premium Volume: Gross written premiums declined 19.7% to $236.4 million, primarily due to a 70.3% drop in the Specialty Admitted Insurance segment ($24.1 million vs. $81.1 million) as the Company selectively exited non-renewed fronting programs. Excess & Surplus Lines premiums remained flat.
- Investment Results: Net investment income increased 6.6% to $21.3 million, driven by growth in structured private credit. However, net realized and unrealized investment losses surged to $6.6 million (vs. $1.4 million prior year), largely due to $4.9 million in losses on bank loan participations and $1.8 million on equity securities.
- Retroactive Reinsurance: The Company recognized $14.2 million of losses related to retroactive reinsurance accounting (specifically the E&S Top Up ADC), which significantly impacted the reported loss ratio. Excluding this, the accident year loss ratio was 66.1%.
Guidance, Outlook, and Risks
- Outlook: Management continues to prioritize profitable growth in small to medium-sized accounts within the Excess & Surplus Lines segment. The Specialty Admitted segment remains focused on low net retention fronting opportunities.
- Reinsurance Capacity: The E&S Top Up Adverse Development Cover (ADC) limit has been reduced to $7.5 million remaining as of March 31, 2026, following $16.2 million of adverse development ceded in Q1. The Company notes that reinsurance capacity remains restricted and pricing is challenging.
- Liquidity: The Company maintains a $212.5 million unsecured revolving credit facility with $210.8 million drawn. Cash and cash equivalents totaled $227.6 million. Operating cash flow (excluding restricted cash) was a use of $0.8 million.
- Risks: Key risks include the uncertainty of loss reserves, potential downgrades in financial strength ratings (currently A- with a negative outlook), and credit exposure to reinsurers and indemnifying parties (specifically regarding the legacy Rasier Commercial Auto book).
Investor Verification Checklist
- Retroactive Reinsurance Impact: Verify the remaining limits on the E&S Top Up ADC ($7.5 million) and the potential for further adverse development to be recognized in future periods.
- Investment Portfolio Quality: Review the $61.1 million in gross unrealized losses on fixed maturity securities and the $4.9 million loss on bank loan participations to assess credit risk exposure.
- Specialty Admitted Segment Strategy: Confirm the long-term viability of the reduced fronting business model following the 70% decline in premiums.
- Domestication Tax Benefits: Monitor the realization of the $14.1 million deferred tax asset related to the 2025 domestication and business interest expense deductions.
- Reinsurance Counterparty Risk: Assess the financial strength of reinsurers, particularly given the concentration of recoverables ($2.0 billion) and the specific exposure to the Rasier Commercial Auto indemnity agreements.